↓ Skip to main content
What is this page? Embed badge

Abstract GS3-02: GS3-02 Camizestrant, a next generation oral SERD vs fulvestrant in post-menopausal women with advanced ER-positive HER2-negative breast cancer: Results of the randomized, multi-dose…

Overview of attention for article published in Cancer Research, March 2023
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (68th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
22 Mendeley
Summary News Dimensions citations
So far, Altmetric has seen 1 news story.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.

This page is provided by Altmetric.